New Treatment Could Extend Preeclampsia Pregnancies Safely

Researchers at Cedars-Sinai just published results that could transform care for people facing the most dangerous pregnancy complication in America.

Preeclampsia causes dangerously high blood pressure during pregnancy, threatening both parent and baby. Right now, doctors have only one real solution: deliver the baby immediately, sometimes months too early.

But a new treatment tested in a small pilot trial offers hope for extending those pregnancies safely. The approach works similarly to kidney dialysis, filtering a harmful protein from the pregnant person's blood.

The team published their positive early results yesterday in Nature Medicine. While the trial was small, the findings suggest this could be the first real treatment option beyond aspirin or emergency delivery.

About 4% of U.S. pregnancies develop preeclampsia. While aspirin helps reduce some risk, it can't cure the condition or prevent its most severe forms.

The earliest and most dangerous cases often force impossible choices. Deliver now and face complications from extreme prematurity, or wait and risk the parent's life.

Why This Inspires

This research represents years of work to find an alternative to that heartbreaking choice. The treatment doesn't just buy time; it could mean healthier outcomes for thousands of families every year.

The dialysis-like approach targets the root problem rather than just managing symptoms. By removing the harmful protein causing the high blood pressure, doctors may be able to safely extend pregnancies that would otherwise end in emergency delivery.

Early trials are just the beginning, but they show the concept works. If larger studies confirm these results, this could become standard care for severe preeclampsia within a few years.

For the families who face this diagnosis, hope is arriving in the form of real medical innovation.